Sun.Jun 06, 2021

article thumbnail

Novo’s obesity drug has serious warnings and barriers to overcome

World of DTC Marketing

SUMMARY: The media headlines promise weight loss for diabetes patients, but Norvo’s new drug is in the same class as other drugs and carries many warnings. Can diabetes patients really stay adherent to a drug for 63 weeks in which 85% of patients report GI side effects and will insurance cover the cost? The headlines read “FDA approves obesity drug that helped people cut weight 15%” But buyer beware.

Drugs 318
article thumbnail

An immunotherapy debate, an NK cell question and the next precision drugs: a closer look at ASCO

Bio Pharma Dive

The year's biggest meeting for cancer drug research is about to wrap up. Here are three key storylines to emerge.

Drugs 258
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Telstar addresses the latest trends in aseptic process solutions at Achema Pulse 2021

Pharma Mirror

Terrassa (Barcelona): Telstar will be exhibiting the latest developments in aseptic technology for pharmaceutical production and integrated turnkey engineering & construction services for process facilities at Achema Pulse 2021. The company will be present at the digital flagship event of the global process industries during the whole of June and will be live during 15-16th June.

Engineer 130
article thumbnail

Cellarity: Transforming Drug Development at the Confluence of Biology and Machine Learning

BioSpace

In the field of drug discovery, one must always begin with the target, right? Not if you ask Cellarity, a quickly emerging biotech company revolutionizing the drug development space.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

5 Ways the Right EPCR Software Can Benefit EMS Organizations

Pharma Mirror

Emergency medical response requires a coordinated effort. It’s a field that burdens people with the task of providing an organized and immediate medical response in an often chaotic and high-pressure environment. To be able to do this in a consistent and timely manner, many emergency medical services (EMS) providers rely on electronic patient care reports (ePCR) solutions. ePCR is critical to the operation of EMS organizations because it allows staff members and response coordinators to stay on

130
130
article thumbnail

With Illumina Acquisition Pending, GRAIL Presents Multi-Cancer Detection Test

BioSpace

Grail presents its first data from the interventional PATHFINDER trial of Galleri, its multi-cancer early detection blood test. Galleri is now available in the U.S. by prescription.

Trials 103

More Trending

article thumbnail

United Therapeutics Now Suing Liquidia for Trade Secret Misappropriation

BioSpace

United claims Liquidia and a former employee misappropriated its trade secrets such as regulatory submissions and detailed financial forecasts for its inhaled treprostinil.

98
article thumbnail

How a Vietnamese raw pork snack could help us keep food fresh, naturally

Scienmag

Fermented meat snack is helping researchers develop a safe, all-natural food preservative Credit: RMIT University A traditional Vietnamese meat snack could hold the key to developing a safe and natural food preservative, addressing the twin global problems of food waste and food-borne illnesses. Key Points Bacteria-killing compound discovered in Nem Chua, a fermented pork snack […].

article thumbnail

ASCO 2021: Fate Therapeutics Stock Jumps on Positive Data from Lymphoma Study

BioSpace

Shares of Fate climbed nearly 4% in premarket trading after it announced positive interim data from a Phase I study of FT516 for patients with relapsed / refractory B-cell lymphoma.

98
article thumbnail

Virginia Tech to advance brain, cancer research with focused ultrasound

Scienmag

Fralin Biomedical Research Institute invests in MRI-guided focused ultrasound facility with support from Edward N. & Della L. Thome Memorial Foundation Credit: Clayton Metz/Virginia Tech By 2034, nearly one-quarter of Americans will have reached retirement age, according to the United States Census Bureau. But as people age, the brain becomes more susceptible to developing disorders, […].

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

FDA Lifts Hold on bluebird bio’s Sickle Cell and Beta-Thalassemia Gene Therapies

BioSpace

The FDA lifted the clinical holds on bluebird bio’s sickle gene therapy and its betibeglogene autotemcel gene therapy for adults, adolescents and children with TDT.

article thumbnail

An ‘atlas’ of the brain’s choroid plexus across the lifespan

Scienmag

New resource for neuroscience maps cell types, secreted proteins, spatial organization, and more Credit: Dani N, Herbst RH, et al. Cell April 30, 2021, DOI 10.1016/j.cell.2021.04.003. Once viewed merely as a producer of the cerebrospinal fluid (CSF) bathing the brain and spinal cord, the choroid plexus is now known to be a key player in […].

Protein 72
article thumbnail

AstraZeneca Redefining Cancer Care in Breast Cancer, Leukemia at ASCO

BioSpace

After three years, 85.9% of patients treated post-surgically with Lynparza were free of invasive breast cancer and second cancers compared to 77.1% of the placebo group.

106
106
article thumbnail

ALPALGA: The search for mountain snow microalgae

Scienmag

Credit: © Jean-Gabriel VALAY/JARDIN DU LAUTARET/UGA/CNRS In a white ocean, well above sea level, the algae thrive. Normally invisible to the naked eye, they are often spotted by hikers trekking through the mountains in late spring as strikingly coloured stretches of snow, in shades of ochre, orange and red. Known as “glacier blood”, this colouring […].

69
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

FDA Action Alert: Alexion, Biogen, Vertex and Royalty

BioSpace

June is turning out to be a busy month for PDUFA dates for the U.S. Food and Drug Administration. Here’s a look at this week’s dates.

Drugs 98
article thumbnail

Spread of Misinformation About Face Masks and COVID-19 by Automated Software on Facebook

JAMA Internal Medicine

This cross-sectional study examines the spread of misinformation regarding the Danish Study to Assess Face Masks for the Protection Against COVID-19 Infection on Facebook.

76
article thumbnail

Merck Investigating Noose Reportedly Found at Durham, North Carolina Plant

BioSpace

An ugly symbol of racism appears to have reared its head at a Merck facility in North Carolina. The pharma giant is investigating reports of a noose found hanging at a construction project on the 262-acre facility.

98
article thumbnail

Global travelers pick up numerous genes that promote microbial resistance

Scienmag

Such genes have potential to spread when travelers return home Carried like stowaways in the guts of international travelers, new and potentially deadly strains of antimicrobial resistant superbugs may be coming to a community near you, suggests new research from Washington University School of Medicine in St. Louis. “Even before the COVID-19 pandemic, we knew […].

Gene 71
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Clinical Catch-Up: June 1-6

BioSpace

With the 2021 American Society of Clinical Oncology meeting held late last week, there is plenty of clinical trial news.

article thumbnail

Climate change increases extreme rainfall and the chance of floods

Scienmag

Climate experts warn that, without urgent action, climate change will continue to cause an increase in the intensity of extreme rainfall that can lead to severe flooding Climate experts warn that, without urgent action, climate change will continue to cause an increase in the intensity of extreme rainfall that can lead to severe flooding. An […].

65
article thumbnail

Novo Nordisk's Wegovy is First and Only Once-Weekly GLP-1 Agonist Approved for Weight Management

BioSpace

Wegovy is the first and only once-weekly GLP-1 receptor agonist that’s been approved for weight control in people living with obesity. This is the same drug used to treat type 2 diabetes.

Drugs 76
article thumbnail

Regulatory Affairs for Medical Device Clinical Trials with Priya Jagasia

Clinical Trial Podcast

Clinical trials are conducted in compliance with regulations. Simply stated, you need a clinical and regulatory strategy when it comes to conduct of clinical trials for medical devices. As a clinical researcher, there have been times I’ve felt lost because I did not understand the regulatory framework. To close this knowledge gap, I thought it would be great to invite Priya Jagasia, Divisional Vice President (DVP) of Regulatory Affairs at Abbott Vascular on the show.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Hospitalized individuals with active cancer more likely to die from COVID-19

Scienmag

Patients with blood cancers at greatest risk of COVID-19 death New research indicates that patients hospitalized with active cancer were more likely to die from COVID-19 than those with a history of cancer or those without any cancer diagnosis. The findings published by Wiley early online in CANCER, a peer-reviewed journal of the American Cancer […].

article thumbnail

Biogen's Aducanumab First Alzheimer's Drug Approved in 20 Years

BioSpace

The U.S. Food and Drug Administration granted approval of Biogen’s aducanumab for the treatment of Alzheimer’s disease.

Drugs 79
article thumbnail

Use of High-Sensitivity Cardiac Troponin in Patients With Kidney Impairment

JAMA Internal Medicine

This randomized clinical trial examines the use of high-sensitivity cardiac troponin testing for patients with kidney impairment.

article thumbnail

RAPS Wisconsin Chapter Webcast: Device Requirements for Drug-Led Combination Products

FDA Law Blog

The RAPS Wisconsin Chapter is hosting a webcast on Wednesday, June 23, 2021, discussing device requirements for drug-led combination products. Hyman, Phelps & McNamara, P.C.’s Adrienne Lenz will be the speaker. This webcast will cover U.S. FDA requirements applicable to sponsors of drug-led drug/device combination products, including device requirements for the quality management system and good manufacturing practices (GMPs), device content to include in a new drug application (NDA), regi

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

FDA ends 7-year obesity drug drought, clearing Novo Nordisk’s Wegovy

pharmaphorum

Novo Nordisk is celebrating the FDA approval of its GLP-1 agonist semaglutide as a treatment for obesity, which it believes has the potential to redefine the market for weight-loss medicines. . Already approved at a lower dose as Ozempic for treating diabetes, the new 2.4 mg once-weekly formulation – which will be sold as Wegovy – is the first new medicine to be approved in the US for obesity since 2014.

Drugs 52
article thumbnail

Novartis Showcases Multiple Clinical Programs At ASCO

BioSpace

Novartis flexed its clinical muscles over the weekend, announcing results from multiple studies including different types of cancer and kidney disease.

59
article thumbnail

Are SARS-CoV-2 Human Challenge Trials Ethical?

JAMA Internal Medicine

This Viewpoint explores the ethics of a UK SARS-CoV-2 human challenge trial.

Trials 77
article thumbnail

Applying mathematics takes ‘friendship paradox’ beyond averages

Scienmag

The friendship paradox is the observation that the degrees of the neighbors of a node within any network will, on average, be greater than the degree of the node itself. In other words: your friends probably have more friends than you do. While the standard framing of the friendship paradox is essentially about averages, significant […].

45
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.